Tranquility Partners’s Pfizer PFE Stock Holding History

Tranquility Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-8,954	Closed	-$227K	–	219
2025 Q1	$227K	Hold	8,954	–	–	0.09%	192
2024 Q4	$238K	Sell	8,954 -870	-9%	-$23.6K	0.09%	189
2024 Q3	$279K	Hold	9,824	–	–	0.1%	179
2024 Q2	$275K	Sell	9,824 -19	-0.2%	-$523	0.11%	183
2024 Q1	$273K	Buy	9,843 +4	+0%	+$111	0.11%	184
2023 Q4	$283K	Sell	9,839 -1,493	-13%	-$45.1K	0.12%	165
2023 Q3	$376K	Buy	11,332 +105	+0.9%	+$3.71K	0.16%	143
2023 Q2	$412K	Hold	11,227	–	–	0.18%	131
2023 Q1	$458K	Hold	11,227	–	–	0.22%	120
2022 Q4	$575K	Buy	11,227 +900	+9%	+$43.1K	0.29%	92
2022 Q3	$452K	Hold	10,327	–	–	0.25%	107
2022 Q2	$541K	Sell	10,327 -567	-5%	-$28.9K	0.28%	99
2022 Q1	$564K	Sell	10,894 -140	-1%	-$7.26K	0.26%	105
2021 Q4	$652K	Buy	11,034 +165	+2%	+$8.18K	0.3%	93
2021 Q3	$467K	Buy	+10,869	New	+$482K	0.24%	111

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Tranquility Partners's PFE Position: Q2 2025 in Review

Tranquility Partners sold out of Pfizer (PFE) in Q2 2025, closing a stake of 8,954 shares — an estimated $227K sold.

Tranquility Partners first reported a position in PFE in Q3 2021 and held it in 15 quarters. The position peaked at $652K in Q4 2021. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

Tranquility Partners reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
Tranquility Partners sold 8,954 Pfizer shares in Q2 2025, an estimated $227K.
Tranquility Partners first reported a position in Pfizer in Q3 2021 and held it in 15 quarters.
Tranquility Partners's Pfizer position peaked at $652K in Q4 2021.
2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Tranquility Partners's 13F filing for Q2 2025, filed 25 Jul 2025.